Wednesday, February 1, 2012

China Botanic Pharmaceutical Ready To Take Off?

China Botanic Pharmaceutical (CBP) is heavy undervalued with a P/E (Price/Earnings ratio) below 2. Despite that investors still seem to be afraid for the unknown. The fraud risk in this company is low in my opinion.

With the appointment of Mr. Zack Zibing Pan to its Board of Directors on October 15, 2011 they got a heavyweight in their ranks. Mr. Pan is now independent director and chairman of the Audit Committee, and a member of the Nomination and Compensation Committee.

Mr. Pan is a Certified Public Accountant, certified by the Oklahoma State Board of Accountancy. He is also a member of the American Institute of Certified Public Accountants (AICPA) and the Oklahoma Society of Certified Public Accountants (OSCPA). Mr. Pan graduated with a Master of Business Administration from the University of Central Oklahoma in 1999. He obtained his Bachelor of Arts from Anhui University, China in 1988.

"We are delighted and honored to welcome Mr. Pan to our board," said Mr. Shaoming Li, Chairman and Chief Executive Officer of China Botanic. "We are looking forward to working with Mr. Pan and believe that he will help enhance China Botanics' corporate governance and bring his industry and finance expertise to the Board. We believe that the appointment of high-caliber directors to our Board underscores our commitment to corporate governance and integrity."

The fact that it still has some institutional holders gives me faith that Good Times Could Occur In The Nearby Future.

6 Institutional Holders
279,426 Total Shares Held

Click on the column header links to resort ascending (^) or descending (v).

Read more:

No comments:

Post a Comment